Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 6/20 | 0.53 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.50 |
| ▸ | CTSL | P07711 | 3/20 | 0.50 |
| ▸ | CTSS | P25774 | 3/20 | 0.50 |
| ▸ | CTSK | P43235 | 3/20 | 0.50 |
| ▸ | TACR1 | P25103 | 2/20 | 0.50 |
| ▸ | CTSH | P09668 | 1/20 | 0.50 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.48 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.47 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.47 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.47 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.46 |
| ▸ | NMBR | P28336 | 1/20 | 0.45 |
| ▸ | GRPR | P30550 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30272509 | 0.90 | CTSL (0.48) | CTSLCTSSCTSKCTSH | |
| SCHEMBL31347814 | 0.90 | C5AR1 (0.48) | CXCR4C5AR1CTSLCTSSCTSK | |
| SCHEMBL30788337 | 0.87 | CXCR4 (0.62) | CXCR4C5AR1CTSLCTSSCTSK | |
| SCHEMBL31003037 | 0.87 | UTS2R (0.54) | UTS2R | |
| SCHEMBL31483961 | 0.85 | C5AR1 (0.59) | CXCR4C5AR1CTSLCTSSCTSK | |
| SCHEMBL30183179 | 0.83 | CTSL (0.58) | CXCR4C5AR1CTSLCTSSCTSK | |
| SCHEMBL31040596 | 0.83 | CTSL (0.59) | CXCR4C5AR1CTSLCTSSCTSK | |
| SCHEMBL29498130 | 0.83 | NTSR2 (0.57) | TACR1NTSR2NTSR1SORT1 | |
| SCHEMBL30311056 | 0.83 | DPP3 (0.52) | — | |
| SCHEMBL30904766 | 0.83 | C5AR1 (0.65) | CXCR4C5AR1CTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115746104-A | Preparation method of Bulevirtide | 深圳市健翔生物制药有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115746103-A | Preparation method of Bulevirtide | 深圳市健翔生物制药有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115746102-A | Method for preparing Bulevirtide by combining solid phase with liquid phase | 深圳市健翔生物制药有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115746102-A | Method for preparing Bulevirtide by combining solid phase with liquid phase | 深圳市健翔生物制药有限公司 | 2023-03-07 | — | — | CN | disclosed |